Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Cancer care in developing countries

The evolving treatment landscape for HER2-positive metastatic breast cancer

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Moles on the skin increase skin cancer risk

Advances in multiple myeloma: Expert panel discussion

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

ecancermedicalscience editor's choice for June 2014

Novel targeting in acute myeloid leukaemia

ASCO 2014 roundup

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer

Upcoming trends in myeloma therapy